Full Text View
Tabular View
No Study Results Posted
Related Studies
Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II)
This study is not yet open for participant recruitment.
Verified by University of Leipzig, June 2007
First Received: June 22, 2007   No Changes Posted
Sponsored by: University of Leipzig
Information provided by: University of Leipzig
ClinicalTrials.gov Identifier: NCT00491036
  Purpose

Patients in cardiogenic shock complicating acute myocardial infarction (AMI) are referred to a tertiary care center for percutaneous coronary intervention (PCI) of the infarct related artery in this multicenter, ran-domized clinical trial. After checking in- and exclusion criteria computerized randomization is performed to either PCI plus intraaortic balloon pump (IABP) insertion and medical treatment or PCI plus medical treatment only.

Intensive care treatment is performed according to standard care including hemodynamic monitoring using a pulmonary artery catheter for optimal volume status adaptation and inotropic drug administration. The IABP will be weaned after hemodynamic stabilization. Primary outcome measure will be 30-day mortality. The secondary outcome measures such as hemody-namic, laboratory and clinical parameters will serve as surrogate for prognosis of the patients.


Condition Intervention
Myocardial Infarction
Shock, Cardiogenic
Device: Intraaortic balloon pump

MedlinePlus related topics: Heart Attack
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Randomized Clinical Study of Intraaortic Balloon Pump Use in Cardiogenic Shock Complicating Acute Myocardial Infarction

Further study details as provided by University of Leipzig:

Primary Outcome Measures:
  • mortality [ Time Frame: 30 day ]

Secondary Outcome Measures:
  • Key secondary endpoint(s): hemodynamic parameters, catecholamine dose, APACHE-II-score, inflammatory markers, serum lactate Assessment of safety: major bleeding complications, peripheral ischemic vascu-lar complications [ Time Frame: 30 days ]

Study Start Date: January 2008
Estimated Study Completion Date: August 2010
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cardiogenic shock complicating acute myocardial (STEMI or NSTEMI) with:

    • Systolic blood pressure < 90 mmHg > 30 min or inotropes required to maintain pressure > 90 mmHg during systole and
    • Signs of pulmonary congestion
  • Signs of impaired organ perfusion:

    • Altered mental status
    • Cold, clammy skin
    • Urine output <30 ml/h
    • Serum lactate >2mmol/l
  • Hemodynamic parameters:

    • Cardiac index  2,0 l/min/m2
    • PCWP > 15 mmHg
  • Informed consent

Exclusion Criteria:

  • Resuscitation > 30 minutes
  • Cerebral deficit with fixed dilated pupils
  • No intrinsic heart action
  • Mechanical infarction complication
  • Onset of shock > 12 h
  • Severe peripheral artery disease
  • Massive lung emboli
  • Aortic regurgitation > II.°
  • Age > 90 years
  • Other severe concomitant disease.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00491036

Contacts
Contact: Holger Thiele, MD +49 341 8651426 thielh@medizin.uni-leipzig.de

Sponsors and Collaborators
University of Leipzig
Investigators
Study Chair: Holger Thiele, MD University of Leipzig
  More Information

No publications provided

Study ID Numbers: 342
Study First Received: June 22, 2007
Last Updated: June 22, 2007
ClinicalTrials.gov Identifier: NCT00491036     History of Changes
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by University of Leipzig:
Acute myocardial infarction
cardiogenic shock
percutaneous coronary intervention
intraaortic balloon counterpulsation
Acute myocardial infarction – cardiogenic shock

Study placed in the following topic categories:
Necrosis
Heart Diseases
Shock
Shock, Cardiogenic
Myocardial Ischemia
Vascular Diseases
Ischemia
Infarction
Myocardial Infarction

Additional relevant MeSH terms:
Necrosis
Heart Diseases
Pathologic Processes
Shock, Cardiogenic
Shock
Myocardial Ischemia
Vascular Diseases
Cardiovascular Diseases
Ischemia
Infarction
Myocardial Infarction

ClinicalTrials.gov processed this record on May 07, 2009